Pharmacokinetics and 180‐day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2–5 years

Eric B. Segal, James W. Wheless, Muhammad Zafar, Evelyn K. Shih, Leock Y. Ngo, Enrique Carrazana, Adrian L. Rabinowicz, Unknown

Open source

DOI
10.1111/epi.18473
Published
2025-07-12
Container
Epilepsia
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/epi.18473,
  title = {Pharmacokinetics and 180‐day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2–5 years},
  author = {Eric B. Segal and James W. Wheless and Muhammad Zafar and Evelyn K. Shih and Leock Y. Ngo and Enrique Carrazana and Adrian L. Rabinowicz and Unknown},
  year = {2025},
  journal = {Epilepsia},
  doi = {10.1111/epi.18473},
  url = {https://doi.org/10.1111/epi.18473}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and 180‐day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2–5 years
AU  - Eric B. Segal
AU  - James W. Wheless
AU  - Muhammad Zafar
AU  - Evelyn K. Shih
AU  - Leock Y. Ngo
AU  - Enrique Carrazana
AU  - Adrian L. Rabinowicz
AU  - Unknown
PY  - 2025
JO  - Epilepsia
DO  - 10.1111/epi.18473
UR  - https://doi.org/10.1111/epi.18473
ER  - 

APA

Segal, E. B., Wheless, J. W., Zafar, M., Shih, E. K., Ngo, L. Y., Carrazana, E., Rabinowicz, A. L., & Unknown (2025). Pharmacokinetics and 180‐day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2–5 years. Epilepsia. https://doi.org/10.1111/epi.18473

Source records